- Business Type:
- Manufacturer
- Year Established:
- 1995
- Total Revenue:
- Above US$100 Million
- Main Markets:
- North America, South America, Southeast Asia, Oceania, Mid East, Eastern Asia
Company Description
Founded in February 2004, Jiangsu Yew Biotechnology Co., Ltd is a High-Tech enterprise which is specially engaged in extracting, isolating and purifying paclitaxel from yew trees.
Our company invested ¥80,000,000 to build the chemical division. We also do paclitaxel market both home and abroad. The initial designed production capacity of paclitaxel was 300kg annually. When the process optimization and the technology improvement are done, the annual production capacity will reach 500kg.